| Janssen-Cilag AG - Prezista 100 mg/ml, orale Suspension | | 65381 | | 01 | | Prezista 100 mg/ml | | orale Suspension | | J05AE10 | | Darunavir | | 23.07.2015 | | |
| | Composition | | darunavirum 100 mg ut darunavirum ethanolum, hydroxypropylcellulosum, cellulosum microcristallinum, carmellosum natricum, acidum citricum monohydricum, sucralosum, acidum hydrochloridum concentratum, aromatica (Geschmacksüberdeckungsaroma), aromatica (Erdbeer), E 219 3.43 mg, aqua purificata ad suspensionem pro 1 ml corresp. natrium 570 µg. | | Packungsbestandteile | | Suspension (oral) | | | | | | Active Agent | Dose |
|---|
| Darunavir | 100 mg/ml |
| | | | Inactive agents | Dose | additional_information |
|---|
| Citric Acid Monohydrate | | | | | | | | | | | | | | | | Carmellose Sodium | | | | | | | | | 3.43 mg/ml | conserv. | | | | | | | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Flasche(n) | PR | PR | A | | No |
|
|
